↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Träfflista för sökning "L773:0195 668X srt2:(2005-2009)"

Search: L773:0195 668X > (2005-2009)

Result 11-20 of 306

Sort/group result

Sort by: Hits per page:

Enumeration	Reference	Cover	Find
11.	Al-Khalili, F, et al. (author) The role of physical fitness in predicting long-term prognosis in middle-aged women surviving acute coronary syndrome 2005 In: EUROPEAN HEART JOURNAL. - 0195-668X. ; 26, s. 218-218 Conference paper (other academic/artistic)
12.	Alam, M, et al. (author) Myocardial performance index determined by Doppler Tissue Imaging in patients with congestive heart failure identifies patients with poor prognosis 2009 In: EUROPEAN HEART JOURNAL. - 0195-668X. ; 30, s. 567-568 Conference paper (other academic/artistic)
13.	Almroth, Henrik, et al. (author) Atorvastatin and persistent atrial fibrillation following cardioversion : a randomized placebo-controlled multicentre study 2009 In: European Heart Journal. - Philadelphia : Oxford University Press (OUP). - 0195-668X .- 1522-9645. ; 30:7, s. 827-833 Journal article (peer-reviewed)abstract AIMS: To evaluate the effect of atorvastatin in achieving stable sinus rhythm (SR) 30 days after electrical cardioversion (CV) in patients with persistent atrial fibrillation (AF). METHODS AND RESULTS: The study included 234 patients. The patients were randomized to treatment with atorvastatin 80 mg daily (n = 118) or placebo (n = 116) in a prospective, double-blinded fashion. Treatment was initiated 14 days before CV and was continued 30 days after CV. The two groups were well-balanced with respect to baseline characteristics. Mean age was 65 +/- 10 years, 76% of the patients were male and 4% had ischaemic heart disease. Study medication was well-tolerated in all patients but one. Before primary endpoint 12 patients were excluded. In the atorvastatin group 99 patients (89%) converted to SR at electrical CV compared with 95 (86%) in the placebo group (P = 0.42). An intention-to-treat analysis with the available data, by randomization group, showed that 57 (51%) in the atorvastatin group and 47 (42%) in the placebo group were in SR 30 days after CV (OR 1.44, 95%CI 0.85-2.44, P = 0.18). CONCLUSION: Atorvastatin was not statistically superior to placebo with regards to maintaining SR 30 days after CV in patients with persistent AF.
14.	Amisten, Stefan, et al. (author) Increased risk of acute myocardial infarction and elevated levels of C-reactive protein in carriersof the Thr-87 variant of the ATP receptor P2Y11. 2007 In: European Heart Journal. - : Oxford University Press (OUP). - 1522-9645 .- 0195-668X. ; 28:1, s. 13-18 Journal article (peer-reviewed)abstract Aims Extracellular ATP acting on the P2Y(11) receptor regulates inflammatory cells. We hypothesized that polymorphisms in the receptor could influence the risk of acute myocardial infarction (AMI). Methods and results In the Malmo diet and cancer AMI case-control study (n = 3732) the P2Y(11) gene Thr-87 polymorphism was present in 19.8% of the controls and 22.9% in AMI patients (OR 1.21; P = 0.03). Stronger associations were found in patients with family history (FH) of AMI, 1.32; early-onset (EO) AMI, 1.43; or EO AMI combined with FH, 1.50; supporting a genetic mechanism. The Thr-87 homozygotes had an even greater risk of AMI, 1.94 (P = 0.04); and 2.48 in the EO AMI subgroup, suggesting a genetic dosage effect. In the cardiovascular risk factor group (n = 6055), 21.3% carried the Thr-87 allele. C-reactive protein was elevated in Thr-87 carriers: 1.6 mg/L vs. 1.3 mg/L (P = 0.001). No difference was seen for blood pressure, lipids, body mass index, smoking, or diabetes mellitus. Conclusion The common Ala-87-Thr polymorphism of the P2Y(11) receptor is associated with AMI and increased levels of C-reactive protein. We hypothesize that an inflammatory mechanism might be involved. The P2Y(11) receptor is a promising new drug target in the prevention of AMI.
15.	Anderson, RE, et al. (author) Are even impaired fasting blood glucose levels preoperatively associated with increased mortality after CABG surgery? 2005 In: European heart journal. - : Oxford University Press (OUP). - 0195-668X .- 1522-9645. ; 26:15, s. 1513-1518 Journal article (peer-reviewed)
16.	Andersson, B, et al. (author) C34T AMPD1 gene polymorphism is a survival factor in male chronic heart failure with preserved left ventricular function 2005 In: EUROPEAN HEART JOURNAL. - 0195-668X. ; 26, s. 377-377 Conference paper (other academic/artistic)
17.	Andrell, P, et al. (author) Long-term effects of spinal cord stimulation in refractory angina pectoris-3-year results from the European Angina Registry Link (EARL) 2009 In: EUROPEAN HEART JOURNAL. - 0195-668X. ; 30, s. 452-453 Conference paper (other academic/artistic)
18.	Angoulvant, D, et al. (author) Microsomal Prostaglandin E Synthase-1 (mPGES-1) plays a role in cellular remodeling and preservation of left ventricular geometry and function after myocardial infarction 2006 In: EUROPEAN HEART JOURNAL. - 0195-668X. ; 27, s. 32-32 Conference paper (other academic/artistic)
19.	Anselmino, M, et al. (author) Glucose lowering treatment in patients with coronary artery disease is prognostically important not only in established but also in newly detected diabetes mellitus: a report from the Euro Heart Survey on Diabetes and the Heart 2008 In: European heart journal. - : Oxford University Press (OUP). - 0195-668X .- 1522-9645. ; 29:2, s. 177-184 Journal article (peer-reviewed)
20.	Back, M (author) Gamma-glutamyltransferase, leukotrienes, and cardiovascular risk 2007 In: European heart journal. - : Oxford University Press (OUP). - 0195-668X .- 1522-9645. ; 28:2, s. 269-269 Journal article (other academic/artistic)

Skapa referenser, mejla, bekava och länka

Permalink

Result 11-20 of 306

Refine your search

Type of publication: journal article (167); conference paper (134); research review (5)

Type of content: other academic/artistic (155); peer-reviewed (151)

Author/Editor: Rydén, L. (23); Wallentin, Lars, 194 ... (23); Swedberg, Karl, 1944 (19); Malmberg, K (16); Sylven, C (16); Grinnemo, KH (12); show more...; Braunschweig, F (10); Janszky, I (10); Norhammar, A. (10); Ohrvik, J (9); Pernow, J (9); Yusuf, S. (9); Mansson-Broberg, A (9); Hammar, N (8); Rosengren, Annika, 1 ... (8); Agewall, S (8); Dickstein, K (8); Jaarsma, Tiny (7); Komajda, M. (7); Corbascio, M (7); Rosenqvist, M (7); de Faire, U (7); Wallentin, Lars (7); Olsson, Bertil (7); Metra, M (6); Wallentin, L (6); Hansson, GK (6); Schenck-Gustafsson, ... (6); Stenestrand, Ulf, 19 ... (6); Nagy, E. (5); Stahlberg, M. (5); Svensson, L (5); Farahmand, B (5); Pfeffer, M. A. (5); Kahan, T (5); Granger, C. B. (5); Lopez-Jimenez, F (5); Filippatos, Gerasimo ... (5); Doughty, RN (5); Whalley, GA (5); James, Stefan, 1964- (5); Hamsten, A (5); Ahnve, S (5); Frostegard, J (5); Al-Khalili, F (5); Lindahl, Bertil, 195 ... (5); De Caterina, Raffael ... (5); Lindback, J (5); Siegbahn, Agneta, 19 ... (5); Gadler, F (5); show less...

University: Karolinska Institutet (200); Uppsala University (52); University of Gothenburg (44); Lund University (25); Linköping University (19); Umeå University (6); show more...; Royal Institute of Technology (4); University of Borås (3); Örebro University (2); Högskolan Dalarna (1); show less...

Language: English (306)

Research subject (UKÄ/SCB): Medical and Health Sciences (58); Social Sciences (1)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - National Library Systems
LIBRIS.kb.se

pil uppåt

Close

Copy and save the link in order to return to this view